Literature DB >> 10932153

Genetic selection for dissociative inhibitors of designated protein-protein interactions.

S H Park1, R T Raines.   

Abstract

Many biological processes rely on protein-protein interactions. These processes include signal transduction, cell cycle regulation, gene regulation, and viral assembly and replication. Moreover, many proteins and enzymes manifest their function as oligomers. We describe here an efficient means to sift through large combinatorial libraries and identify molecules that block the interaction of target proteins in vivo. The power of this approach is demonstrated by the identification of nine-residue peptides from a combinatorial library that inhibit the intracellular dimerization of HIV-1 protease. Fewer than 1 in 106 peptides do so. In vitro biochemical analyses of one such peptide demonstrate that it acts by dissociating HIV-1 protease into monomers, which are inactive catalysts. Inhibition is enhanced further by dimerizing the peptide. This approach enables the facile identification of new molecules that control cellular processes.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10932153      PMCID: PMC2811168          DOI: 10.1038/78451

Source DB:  PubMed          Journal:  Nat Biotechnol        ISSN: 1087-0156            Impact factor:   54.908


  52 in total

1.  Resistance to HIV protease inhibitors: a comparison of enzyme inhibition and antiviral potency.

Authors:  R M Klabe; L T Bacheler; P J Ala; S Erickson-Viitanen; J L Meek
Journal:  Biochemistry       Date:  1998-06-16       Impact factor: 3.162

2.  Discrepant responses to triple combination antiretroviral therapy in advanced HIV disease.

Authors:  C Piketty; P Castiel; L Belec; D Batisse; A Si Mohamed; J Gilquin; G Gonzalez-Canali; D Jayle; M Karmochkine; L Weiss; J P Aboulker; M D Kazatchkine
Journal:  AIDS       Date:  1998-05-07       Impact factor: 4.177

3.  Oligomerization properties of GCN4 leucine zipper e and g position mutants.

Authors:  X Zeng; H Zhu; H A Lashuel; J C Hu
Journal:  Protein Sci       Date:  1997-10       Impact factor: 6.725

Review 4.  HIV-protease inhibitors.

Authors:  C Flexner
Journal:  N Engl J Med       Date:  1998-04-30       Impact factor: 91.245

5.  Buried asparagines determine the dimerization specificities of leucine zipper mutants.

Authors:  X Zeng; A M Herndon; J C Hu
Journal:  Proc Natl Acad Sci U S A       Date:  1997-04-15       Impact factor: 11.205

6.  A transient precursor of the HIV-1 protease. Isolation, characterization, and kinetics of maturation.

Authors:  E M Wondrak; N T Nashed; M T Haber; D M Jerina; J M Louis
Journal:  J Biol Chem       Date:  1996-02-23       Impact factor: 5.157

7.  The inhibition of human immunodeficiency virus proteases by 'interface peptides'.

Authors:  H J Schramm; J Boetzel; J Büttner; E Fritsche; W Göhring; E Jaeger; S König; O Thumfart; T Wenger; N E Nagel; W Schramm
Journal:  Antiviral Res       Date:  1996-05       Impact factor: 5.970

8.  Declining morbidity and mortality among patients with advanced human immunodeficiency virus infection. HIV Outpatient Study Investigators.

Authors:  F J Palella; K M Delaney; A C Moorman; M O Loveless; J Fuhrer; G A Satten; D J Aschman; S D Holmberg
Journal:  N Engl J Med       Date:  1998-03-26       Impact factor: 91.245

9.  Trans-dominant inhibitory human immunodeficiency virus type 1 protease monomers prevent protease activation and virion maturation.

Authors:  L M Babé; J Rosé; C S Craik
Journal:  Proc Natl Acad Sci U S A       Date:  1995-10-24       Impact factor: 11.205

10.  Interaction between cAMP-dependent protein kinase catalytic subunit and peptide inhibitors analyzed with lambda repressor fusions.

Authors:  R Jappelli; S Brenner
Journal:  J Mol Biol       Date:  1996-06-21       Impact factor: 5.469

View more
  12 in total

1.  Bacteria-based in vivo peptide library screening using biopanning approach.

Authors:  Ji-Hyeon Choi; Sang-Hyun Park
Journal:  J Microbiol       Date:  2011-11-09       Impact factor: 3.422

Review 2.  Diversity in genetic in vivo methods for protein-protein interaction studies: from the yeast two-hybrid system to the mammalian split-luciferase system.

Authors:  Bram Stynen; Hélène Tournu; Jan Tavernier; Patrick Van Dijck
Journal:  Microbiol Mol Biol Rev       Date:  2012-06       Impact factor: 11.056

3.  Stepwise assembly of functional C-terminal REST/NRSF transcriptional repressor complexes as a drug target.

Authors:  Ken Inui; Zongpei Zhao; Juan Yuan; Sakthidasan Jayaprakash; Le T M Le; Srdja Drakulic; Bjoern Sander; Monika M Golas
Journal:  Protein Sci       Date:  2017-03-12       Impact factor: 6.725

4.  A systematic method for identifying small-molecule modulators of protein-protein interactions.

Authors:  Alexander R Horswill; Sergey N Savinov; Stephen J Benkovic
Journal:  Proc Natl Acad Sci U S A       Date:  2004-10-21       Impact factor: 11.205

5.  Identification of antituberculosis agents that target ribosomal protein interactions using a yeast two-hybrid system.

Authors:  Yuan Lin; Yan Li; Yuanjun Zhu; Jing Zhang; Yongzhen Li; Xiao Liu; Wei Jiang; Shishan Yu; Xue-Fu You; Chunling Xiao; Bin Hong; Yanchang Wang; Jian-Dong Jiang; Shuyi Si
Journal:  Proc Natl Acad Sci U S A       Date:  2012-10-08       Impact factor: 11.205

6.  DNA-protein π-interactions in nature: abundance, structure, composition and strength of contacts between aromatic amino acids and DNA nucleobases or deoxyribose sugar.

Authors:  Katie A Wilson; Jennifer L Kellie; Stacey D Wetmore
Journal:  Nucleic Acids Res       Date:  2014-04-17       Impact factor: 16.971

7.  Genetic selection for peptide inhibitors of angiogenin.

Authors:  Bryan D Smith; Ronald T Raines
Journal:  Protein Eng Des Sel       Date:  2008-02-28       Impact factor: 1.650

8.  Screening peptide/protein libraries fused to the lambda repressor DNA-binding domain in E. coli cells.

Authors:  Leonardo Mariño-Ramírez; Lisa Campbell; James C Hu
Journal:  Methods Mol Biol       Date:  2003

9.  Targeting human immunodeficiency virus type 1 assembly, maturation and budding.

Authors:  Johanna Wapling; Seema Srivastava; Miranda Shehu-Xhilaga; Gilda Tachedjian
Journal:  Drug Target Insights       Date:  2007-07-20

10.  Promoter strength driving TetR determines the regulatory properties of Tet-controlled expression systems.

Authors:  Christiane Georgi; Julia Buerger; Wolfgang Hillen; Christian Berens
Journal:  PLoS One       Date:  2012-07-27       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.